Improving Outcomes for Hereditary Angioedema

ACPE UAN #:   0233-0000-17-040-H01-P

Release Date:  May 10, 2017

Expiration Date:  May 10, 2019

Activity Type:  Knowledge-based  

Credit Hours:  1.0 contact hours (0.1 CEU)

Activity Fee:  There is no fee to participate in this home study activity. 

Target Audience

This home study activity has been designed to meet the educational needs of pharmacists in managed care settings.

Activity Overview:

Hereditary angioedema (HAE) affects approximately 1 in 50,000 people and can cause severe, potentially life-threatening swelling. HAE is often misdiagnosed and inappropriately managed for years because symptoms are frequently mistaken for allergic reactions. Patients with HAE report lower health-related quality-of-life, including increased rates of depression and reduced productivity at school and work. In efforts to increase patient quality of life, how can managed care pharmacists and benefits managers improve patient care, including timely access to appropriate medications and reduced hospitalizations?

This program will address the clinical features of HAE, issues surrounding diagnosis, new and emerging medication options, and methods for increasing patient satisfaction and outcomes through management of both direct and indirect HAE treatment costs.

Learning Objectives 

At the completion of this activity, participants should be able to:

  1. Discuss the types of hereditary angioedema and their prevalence in the population.
  2. Explain the impact that the time from symptom appearance to diagnosis has on patient satisfaction and outcomes.
  3. Outline guidelines for the treatment of hereditary angioedema.
  4. Identify at least two medications available for the treatment of hereditary angioedema and at least one medication in the pipeline and how it may fit into current treatment guidelines.
  5. Describe methods for increasing patient satisfaction and outcomes through management of direct and indirect hereditary angioedema treatment costs.

Schedule of Educational Activity

  • Recognizing and Treating Hereditary Angioedema - Marc Riedl, MD, MS
  • Managing Outcomes in Patients with Hereditary Angioedema - Michael Toscani, PharmD 

CPE Requirements:   

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live webinar activity on May 10, 2017.  CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor.  Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.

System Technical Requirements/Viewing Requirements: System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities you should have a basic comfort level using a computer and navigating web sites.  View the minimum technical and system requirements for continuing education online learning activities.

As an ACPE-accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of CPE activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.

Statement of Commercial Support

This educational activity is supported by an unrestricted education grant from Shire. 

Christine L. Cooper, PharmD
Education Program Manager
Academy of Managed Care Pharmacy
Alexandria, Virginia

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE UAN #0233-0000-17-040-H01-P 1 Contact Hour May 10, 2017 - May 10, 2019